These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 33949487

  • 1. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
    Lin M, Zou S, Liao X, Chen Y, Luo D, Ji L, Chao H.
    Chem Commun (Camb); 2021 May 04; 57(36):4408-4411. PubMed ID: 33949487
    [Abstract] [Full Text] [Related]

  • 2. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
    Mo J, Mai Le NP, Priefer R.
    Eur J Med Chem; 2021 Dec 05; 225():113770. PubMed ID: 34403979
    [Abstract] [Full Text] [Related]

  • 3. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S, Zhao J, Wang X, Xu G, Gou S, Zhao Q.
    Inorg Chem; 2020 Aug 03; 59(15):11193-11204. PubMed ID: 32702972
    [Abstract] [Full Text] [Related]

  • 4. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.
    Zhao F, Wang W, Wu W.
    Dalton Trans; 2021 Mar 16; 50(10):3536-3541. PubMed ID: 33599670
    [Abstract] [Full Text] [Related]

  • 5. A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.
    Karges J, Yempala T, Tharaud M, Gibson D, Gasser G.
    Angew Chem Int Ed Engl; 2020 Apr 27; 59(18):7069-7075. PubMed ID: 32017379
    [Abstract] [Full Text] [Related]

  • 6. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
    Liu X, Li G, Xie M, Guo S, Zhao W, Li F, Liu S, Zhao Q.
    Dalton Trans; 2020 Aug 18; 49(32):11192-11200. PubMed ID: 32748922
    [Abstract] [Full Text] [Related]

  • 7. The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers.
    Qiu K, Wen Y, Ouyang C, Liao X, Liu C, Rees TW, Zhang Q, Ji L, Chao H.
    Chem Commun (Camb); 2019 Sep 17; 55(75):11235-11238. PubMed ID: 31469153
    [Abstract] [Full Text] [Related]

  • 8. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
    Li J, Zeng L, Xiong K, Rees TW, Jin C, Wu W, Chen Y, Ji L, Chao H.
    Chem Commun (Camb); 2019 Sep 10; 55(73):10972-10975. PubMed ID: 31453611
    [Abstract] [Full Text] [Related]

  • 9. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L, Yin H, Jabed MA, Hetu M, Wang C, Monro S, Zhu X, Kilina S, McFarland SA, Sun W.
    Inorg Chem; 2017 Mar 20; 56(6):3245-3259. PubMed ID: 28263079
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
    Liu ZY, Zhang J, Sun YM, Zhu CF, Lu YN, Wu JZ, Li J, Liu HY, Ye Y.
    J Mater Chem B; 2020 Jan 22; 8(3):438-446. PubMed ID: 31833531
    [Abstract] [Full Text] [Related]

  • 11. NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.
    Lifshits LM, Roque JA, Cole HD, Thummel RP, Cameron CG, McFarland SA.
    Chembiochem; 2020 Dec 11; 21(24):3594-3607. PubMed ID: 32761725
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.
    Roy S, Colombo E, Vinck R, Mari C, Rubbiani R, Patra M, Gasser G.
    Chembiochem; 2020 Oct 15; 21(20):2966-2973. PubMed ID: 32473056
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J, Novohradsky V, Kostrhunova H, Štarha P, Trávníček Z, Kasparkova J, Brabec V.
    Dalton Trans; 2018 Sep 11; 47(35):12197-12208. PubMed ID: 30112527
    [Abstract] [Full Text] [Related]

  • 18. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
    Zhao X, Li M, Sun W, Fan J, Du J, Peng X.
    Chem Commun (Camb); 2018 Jun 21; 54(51):7038-7041. PubMed ID: 29873358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.
    Zeng L, Kuang S, Li G, Jin C, Ji L, Chao H.
    Chem Commun (Camb); 2017 Feb 07; 53(12):1977-1980. PubMed ID: 28119967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.